SCHEMBL5157280

SCHEMBL5157280

Cc1cccc(-c2nc3cc(C(=O)O)ccn3c2-c2ccnc([AsH2])n2)n1

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 9/20 0.38
AKT1 P31749 1/20 0.38
AKT2 P31751 1/20 0.38
TGFBR2 P37173 1/20 0.36
CCNE1 P24864 3/20 0.35
CDK2 P24941 3/20 0.35
CDK4 P11802 2/20 0.35
KDR P35968 2/20 0.35
MAPK14 Q16539 1/20 0.35
PLAU P00749 1/20 0.35
SYK P43405 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL409134 0.88 CDK4 (0.47) CDK2CDK4
SCHEMBL5276382 0.86 CDK2 (0.53) CCNE1CDK2CDK4KDRSYK
SCHEMBL27803615 0.85 EGFR (0.42) TGFBR1AKT1AKT2TGFBR2CCNE1
SCHEMBL415581 0.80 CDK4 (0.47) TGFBR1CDK2CDK4MAPK14
SCHEMBL412686 0.78 IGF1R (0.49) AKT1AKT2CDK2CDK4
SCHEMBL414224 0.76 AKT1 (0.46) AKT1AKT2CDK2CDK4
SCHEMBL413069 0.76 IGF1R (0.47) CDK2CDK4
SCHEMBL414374 0.76 IGF1R (0.46) TGFBR1CDK2CDK4KDR
SCHEMBL411784 0.76 IGF1R (0.47) CDK2CDK4
SCHEMBL409151 0.76 IGF1R (0.47) CDK2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546112-A4 IMIDAZOLOPYRIDINES AND METHODS OF MAKING AND USING THE SAME BIOGEN IDEC INC (US) 2006-06-07 EP claimed
EP-1546112-A2 IMIDAZOLOPYRIDINES AND METHODS OF MAKING AND USING THE SAME Biogen Idec MA Inc. (US) 2005-06-29 EP claimed
WO-2004021989-A2 IMIDAZOLOPYRIDINES AND METHODS OF MAKING AND USING THE SAME BIOGEN IDEC MA INC. (US) 2004-03-18 WO claimed
WO-2008013928-A2 TREATMENT OF CANCER WITH INTERFERON GENE DELIVERY IN COMBINATION WITH A TGF-BETA INHIBITOR BIOGEN IDEC MA INC. (US) 2008-01-31 WO disclosed